Published in
Elsevier, European Journal of Cancer, (118), p. 178-186, 2019
DOI: 10.1016/j.ejca.2019.05.004
Links
Tools
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial
Journal article published in 2019 by
Francesco Perrone 
,
Michelino De Laurentiis,
Sabino De Placido,
Michele Orditura,
Saverio Cinieri,
Ferdinando Riccardi,
Angela Stefania Ribecco,
Carlo Putzu,
Lucia Del Mastro,
Emanuela Rossi,
Vincenza Tinessa,
Anna Maria Mosconi,
Francesco Nuzzo,
Francesca Di Rella,
Adriano Gravina
and other authors.
,
Michelino De Laurentiis,
Sabino De Placido,
Michele Orditura,
Saverio Cinieri,
Ferdinando Riccardi,
Angela Stefania Ribecco,
Carlo Putzu,
Lucia Del Mastro,
Emanuela Rossi,
Vincenza Tinessa,
Anna Maria Mosconi,
Francesco Nuzzo,
Francesca Di Rella,
Adriano Gravina
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 